Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Cento

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Infection|June 26, 2013
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigenValeria Cento, Formijn Van Hemert, Maria Neumann-Fraune, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 5, 2025
Why do echinocandins fail? Identifying Key Predictors to Improve Clinical Outcomes of Candida Bloodstream Infections: a Retrospective Multicentre Cohort StudyDavide Fiore Bavaro, Lucia Diella, Alessandro De Angelis, et al.
Expert Review of Anti-Infective Therapy|December 25, 2018
Real life experiences in HCV management in 2018Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.
The Journal of Infection|December 3, 2014
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionCarmen Mirabelli, Matteo Surdo, Formijn Van Hemert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Daniele Di Paolo, Domenico Di Carlo, et al.
Scientific Reports|June 14, 2018
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in ItalyAda Bertoli, Maria Chiara Sorbo, Marianna Aragri, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 18, 2026
Monotherapy vs combination therapy for Enterococcus faecalis bacteremia: a target trial emulationMichele Bartoletti, Elena Rosselli Del Turco, Linda Bussini, et al.
Viruses|April 30, 2021
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1bMohammad Alkhatib, Velia Chiara Di Maio, Valentina De Murtas, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2026
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteremia: external validation with decision curve analysisBenedetta Varisco, Daniele Piovani, Elena Rosselli Del Turco, et al.
Plos One|May 26, 2017
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimensValeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Infection|June 26, 2013
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigenValeria Cento, Formijn Van Hemert, Maria Neumann-Fraune, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 5, 2025
Why do echinocandins fail? Identifying Key Predictors to Improve Clinical Outcomes of Candida Bloodstream Infections: a Retrospective Multicentre Cohort StudyDavide Fiore Bavaro, Lucia Diella, Alessandro De Angelis, et al.
Expert Review of Anti-Infective Therapy|December 25, 2018
Real life experiences in HCV management in 2018Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.
The Journal of Infection|December 3, 2014
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionCarmen Mirabelli, Matteo Surdo, Formijn Van Hemert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Daniele Di Paolo, Domenico Di Carlo, et al.
Scientific Reports|June 14, 2018
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in ItalyAda Bertoli, Maria Chiara Sorbo, Marianna Aragri, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 18, 2026
Monotherapy vs combination therapy for Enterococcus faecalis bacteremia: a target trial emulationMichele Bartoletti, Elena Rosselli Del Turco, Linda Bussini, et al.
Viruses|April 30, 2021
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1bMohammad Alkhatib, Velia Chiara Di Maio, Valentina De Murtas, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2026
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteremia: external validation with decision curve analysisBenedetta Varisco, Daniele Piovani, Elena Rosselli Del Turco, et al.
Plos One|May 26, 2017
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimensValeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo, et al.
Pageof 9